Extendicare (EXE) Competitors

C$33.13 -0.18 (-0.54%)

As of 05/14/2026 04:17 PM Eastern

EXE vs. SIA, DNTL, WELL, DR, and NLH

Should you buy Extendicare stock or one of its competitors? MarketBeat compares Extendicare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Extendicare include Sienna Senior Living (SIA), dentalcorp (DNTL), WELL Health Technologies (WELL), Medical Facilities (DR), and Nova Leap Health (NLH). These companies are all part of the "medical care facilities" industry.

How does Extendicare compare to Sienna Senior Living?

Extendicare (TSE:EXE) and Sienna Senior Living (TSE:SIA) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

20.2% of Extendicare shares are owned by institutional investors. Comparatively, 26.0% of Sienna Senior Living shares are owned by institutional investors. 13.9% of Extendicare shares are owned by insiders. Comparatively, 0.1% of Sienna Senior Living shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Extendicare had 4 more articles in the media than Sienna Senior Living. MarketBeat recorded 9 mentions for Extendicare and 5 mentions for Sienna Senior Living. Sienna Senior Living's average media sentiment score of 0.89 beat Extendicare's score of 0.44 indicating that Sienna Senior Living is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Extendicare	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sienna Senior Living	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Extendicare has a beta of 1.273223, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Sienna Senior Living has a beta of 0.95207, indicating that its stock price is 5% less volatile than the broader market.

Extendicare currently has a consensus target price of C$31.89, suggesting a potential downside of 3.75%. Sienna Senior Living has a consensus target price of C$26.09, suggesting a potential upside of 16.74%. Given Sienna Senior Living's higher possible upside, analysts plainly believe Sienna Senior Living is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14
Sienna Senior Living	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00

Extendicare has a net margin of 6.99% compared to Sienna Senior Living's net margin of 4.34%. Extendicare's return on equity of 45.35% beat Sienna Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.99%	45.35%	7.16%
Sienna Senior Living	4.34%	6.44%	3.58%

Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.5%. Sienna Senior Living pays an annual dividend of C$0.94 per share and has a dividend yield of 4.2%. Extendicare pays out 37.2% of its earnings in the form of a dividend. Sienna Senior Living pays out 195.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.75B	1.79	C$65.46M	C$1.36	24.38
Sienna Senior Living	C$1.05B	2.27	C$33.51M	C$0.48	46.56

Summary

Extendicare beats Sienna Senior Living on 11 of the 18 factors compared between the two stocks.

How does Extendicare compare to dentalcorp?

dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
dentalcorp	C$1.66B	1.32	-C$80.68M	-C$0.14	N/A
Extendicare	C$1.75B	1.79	C$65.46M	C$1.36	24.38

In the previous week, Extendicare had 9 more articles in the media than dentalcorp. MarketBeat recorded 9 mentions for Extendicare and 0 mentions for dentalcorp. Extendicare's average media sentiment score of 0.44 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
dentalcorp	Neutral
Extendicare	Neutral

dentalcorp presently has a consensus target price of C$11.00, indicating a potential upside of 0.00%. Extendicare has a consensus target price of C$31.89, indicating a potential downside of 3.75%. Given dentalcorp's higher probable upside, equities analysts plainly believe dentalcorp is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
dentalcorp	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14

Extendicare has a net margin of 6.99% compared to dentalcorp's net margin of -1.64%. Extendicare's return on equity of 45.35% beat dentalcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
dentalcorp	-1.64%	-1.54%	0.77%
Extendicare	6.99%	45.35%	7.16%

dentalcorp pays an annual dividend of C$0.08 per share and has a dividend yield of 0.7%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.5%. dentalcorp pays out -53.6% of its earnings in the form of a dividend. Extendicare pays out 37.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

dentalcorp has a beta of 1.469634, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.273223, suggesting that its share price is 27% more volatile than the broader market.

17.9% of dentalcorp shares are owned by institutional investors. Comparatively, 20.2% of Extendicare shares are owned by institutional investors. 0.2% of dentalcorp shares are owned by company insiders. Comparatively, 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Extendicare beats dentalcorp on 16 of the 19 factors compared between the two stocks.

How does Extendicare compare to WELL Health Technologies?

WELL Health Technologies (TSE:WELL) and Extendicare (TSE:EXE) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation.

Extendicare has a net margin of 6.99% compared to WELL Health Technologies' net margin of 1.82%. Extendicare's return on equity of 45.35% beat WELL Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WELL Health Technologies	1.82%	3.15%	2.07%
Extendicare	6.99%	45.35%	7.16%

WELL Health Technologies presently has a consensus target price of C$6.25, indicating a potential upside of 58.23%. Extendicare has a consensus target price of C$31.89, indicating a potential downside of 3.75%. Given WELL Health Technologies' higher probable upside, equities analysts plainly believe WELL Health Technologies is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WELL Health Technologies	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14

5.4% of WELL Health Technologies shares are owned by institutional investors. Comparatively, 20.2% of Extendicare shares are owned by institutional investors. 6.8% of WELL Health Technologies shares are owned by company insiders. Comparatively, 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

WELL Health Technologies has a beta of 0.933646, indicating that its stock price is 7% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.273223, indicating that its stock price is 27% more volatile than the broader market.

In the previous week, Extendicare had 7 more articles in the media than WELL Health Technologies. MarketBeat recorded 9 mentions for Extendicare and 2 mentions for WELL Health Technologies. WELL Health Technologies' average media sentiment score of 0.73 beat Extendicare's score of 0.44 indicating that WELL Health Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
WELL Health Technologies	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Extendicare	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

WELL Health Technologies has higher earnings, but lower revenue than Extendicare. Extendicare is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WELL Health Technologies	C$1.47B	0.68	C$73.76M	C$0.11	35.91
Extendicare	C$1.75B	1.79	C$65.46M	C$1.36	24.38

Summary

Extendicare beats WELL Health Technologies on 13 of the 17 factors compared between the two stocks.

How does Extendicare compare to Medical Facilities?

Medical Facilities (TSE:DR) and Extendicare (TSE:EXE) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Medical Facilities has a net margin of 8.51% compared to Extendicare's net margin of 6.99%. Extendicare's return on equity of 45.35% beat Medical Facilities' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medical Facilities	8.51%	31.06%	13.60%
Extendicare	6.99%	45.35%	7.16%

Extendicare has a consensus target price of C$31.89, indicating a potential downside of 3.75%. Given Extendicare's stronger consensus rating and higher possible upside, analysts clearly believe Extendicare is more favorable than Medical Facilities.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Facilities	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14

Medical Facilities pays an annual dividend of C$0.26 per share and has a dividend yield of 1.5%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.5%. Medical Facilities pays out 23.8% of its earnings in the form of a dividend. Extendicare pays out 37.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

15.0% of Medical Facilities shares are owned by institutional investors. Comparatively, 20.2% of Extendicare shares are owned by institutional investors. 0.4% of Medical Facilities shares are owned by insiders. Comparatively, 13.9% of Extendicare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Medical Facilities has a beta of 0.566457, suggesting that its share price is 43% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.273223, suggesting that its share price is 27% more volatile than the broader market.

In the previous week, Extendicare had 9 more articles in the media than Medical Facilities. MarketBeat recorded 9 mentions for Extendicare and 0 mentions for Medical Facilities. Medical Facilities' average media sentiment score of 0.68 beat Extendicare's score of 0.44 indicating that Medical Facilities is being referred to more favorably in the media.

Company	Overall Sentiment
Medical Facilities	Positive
Extendicare	Neutral

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medical Facilities	C$260.72M	1.18	C$17.17M	C$1.09	16.03
Extendicare	C$1.75B	1.79	C$65.46M	C$1.36	24.38

Summary

Extendicare beats Medical Facilities on 15 of the 19 factors compared between the two stocks.

How does Extendicare compare to Nova Leap Health?

Nova Leap Health (CVE:NLH) and Extendicare (TSE:EXE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Extendicare has higher revenue and earnings than Nova Leap Health. Nova Leap Health is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nova Leap Health	C$31.47M	1.17	-C$300.30K	-C$0.00	N/A
Extendicare	C$1.75B	1.79	C$65.46M	C$1.36	24.38

Extendicare has a net margin of 6.99% compared to Nova Leap Health's net margin of 0.64%. Extendicare's return on equity of 45.35% beat Nova Leap Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nova Leap Health	0.64%	1.10%	2.77%
Extendicare	6.99%	45.35%	7.16%

Extendicare has a consensus target price of C$31.89, indicating a potential downside of 3.75%. Given Extendicare's stronger consensus rating and higher probable upside, analysts clearly believe Extendicare is more favorable than Nova Leap Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nova Leap Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	3.14

Nova Leap Health has a beta of 2.444711, meaning that its share price is 144% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.273223, meaning that its share price is 27% more volatile than the broader market.

0.0% of Nova Leap Health shares are owned by institutional investors. Comparatively, 20.2% of Extendicare shares are owned by institutional investors. 40.8% of Nova Leap Health shares are owned by insiders. Comparatively, 13.9% of Extendicare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Extendicare had 8 more articles in the media than Nova Leap Health. MarketBeat recorded 9 mentions for Extendicare and 1 mentions for Nova Leap Health. Extendicare's average media sentiment score of 0.44 beat Nova Leap Health's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nova Leap Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Extendicare	0 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Extendicare beats Nova Leap Health on 15 of the 17 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXE vs. The Competition

Export

Metric	Extendicare	Medical Care Facilities Industry	Medical Sector	TSE Exchange
Market Cap	C$3.14B	C$1.60B	C$6.34B	C$11.99B
Dividend Yield	1.53%	3.68%	2.80%	6.22%
P/E Ratio	24.38	8.93	20.90	36.98
Price / Sales	1.79	19.11	549.88	11.92
Price / Cash	3.20	7.90	43.26	82.42
Price / Book	8.04	1.78	9.93	4.62
Net Income	C$65.46M	C$63.03M	C$3.55B	C$299.62M
7 Day Performance	-0.93%	1.43%	1.70%	0.30%
1 Month Performance	11.96%	-0.14%	0.49%	1.39%
1 Year Performance	128.17%	22.25%	39.41%	57.83%

Extendicare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXE Extendicare	1.8156 of 5 stars	C$33.13 -0.5%	C$31.89 -3.7%	+131.8%	C$3.14B	C$1.75B	24.38	23,000	Earnings Report Analyst Forecast
SIA Sienna Senior Living	2.6456 of 5 stars	C$22.22 -1.6%	C$26.09 +17.4%	+28.7%	C$2.36B	C$1.05B	46.29	12,000
DNTL dentalcorp	N/A	C$11.00 +0.1%	C$11.00	+28.2%	C$2.19B	C$1.66B	N/A	9,950
WELL WELL Health Technologies	2.9984 of 5 stars	C$4.08 +0.2%	C$6.25 +53.2%	-3.4%	C$1.04B	C$1.47B	37.09	510	Positive News Earnings Report
DR Medical Facilities	N/A	C$17.18 +2.4%	N/A	+13.9%	C$302.08M	C$260.72M	15.76	1,833	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:EXE) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Summary

How does Extendicare compare to dentalcorp?

Summary

How does Extendicare compare to WELL Health Technologies?

Summary

How does Extendicare compare to Medical Facilities?

Summary

How does Extendicare compare to Nova Leap Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Do institutionals & insiders hold more shares of EXE or SIA?

Does the media favor EXE or SIA?

Which has more risk & volatility, EXE or SIA?

Do analysts prefer EXE or SIA?

Is EXE or SIA more profitable?

Is EXE or SIA a better dividend stock?

Which has higher valuation and earnings, EXE or SIA?

Summary

How does Extendicare compare to dentalcorp?

Which has better valuation and earnings, DNTL or EXE?

Does the media prefer DNTL or EXE?

Do analysts prefer DNTL or EXE?

Is DNTL or EXE more profitable?

Is DNTL or EXE a better dividend stock?

Which has more risk & volatility, DNTL or EXE?

Do institutionals and insiders believe in DNTL or EXE?

Summary

How does Extendicare compare to WELL Health Technologies?

Is WELL or EXE more profitable?

Do analysts prefer WELL or EXE?

Do institutionals & insiders believe in WELL or EXE?

Which has more volatility & risk, WELL or EXE?

Does the media favor WELL or EXE?

Which has better earnings and valuation, WELL or EXE?

Summary

How does Extendicare compare to Medical Facilities?

Is DR or EXE more profitable?

Do analysts recommend DR or EXE?

Is DR or EXE a better dividend stock?

Do insiders & institutionals believe in DR or EXE?

Which has more risk & volatility, DR or EXE?

Does the media refer more to DR or EXE?

Which has better valuation & earnings, DR or EXE?

Summary

How does Extendicare compare to Nova Leap Health?

Which has better valuation & earnings, NLH or EXE?

Is NLH or EXE more profitable?

Do analysts recommend NLH or EXE?

Which has more risk & volatility, NLH or EXE?

Do insiders and institutionals believe in NLH or EXE?

Does the media favor NLH or EXE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools